Methodology

All entries for: ENCell Co., Ltd.

February 5, 2026

ENCell Co., Ltd.

Orphan Drug Designation

treatment of Duchenne muscular dystrophy

Disease Area: Rare Disease
Source
Source
Scroll to Top